Validation of measurement-guided 3d vmat dose reconstruction on a heterogeneous anthropomorphic phantom

Journal of Applied Clinical Medical Physics

Volumn 14, Issue 4, 2013, Pages 70-84

  Opp, Daniel ^a   Nelms, Benjamin E ^b   Zhang, Geoffrey ^a   Stevens, Craig ^a   Feygelman, Vladimir ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Canis Lupus LLC   (United States)

Author keywords

Intensity modulation; Patient dose reconstruction; Phantoms; Treatment verification; VMAT QA

Indexed keywords

EID: 84880653968     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v14i4.4154     Document Type: Article

References (41)

1. Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003;30(8):2089-115.
2. ACR. ACR -ASTRO Practice guideline for intensity modulated radiation therapy (IMRT). Available from: http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/IMRT.pdf. [cited 2012 6/18/2012]
3. Moran JM, Dempsey M, Eisbruch A, et al. Safety considerations for IMRT: executive summary. Pract Radiat Oncol. 2011;1(3):190-95.
4. Poppe B, Blechschmidt A, Djouguela A, et al. Two-dimensional ionization chamber arrays for IMRT plan verification. Med Phys. 2006;33(4):1005-15.
5. Herzen J, Todorovic M, Cremers F, et al. Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine. Phys Med Biol. 2007;52(4):1197-208.
6. Jursinic PA and Nelms BE. A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery. Med Phys. 2003;30(5):870-79.
7. Kozelka J, Robinson J, Nelms B, Zhang G, Saviskij D, Feygelman V. Optimizing the accuracy of a helical diode array dosimeter: a comprehensive calibration methodology coupled with a novel virtual inclinometer. Med Phys. 2011;38(9):5021-32.
8. Letourneau D, Publicover J, Kozelka J, Moseley DJ, Jaffray DA. Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy. Med Phys. 2009;36(5):1813-21.
9. Yan G, Lu B, Kozelka J, Liu C, Li JG. Calibration of a novel four-dimensional diode array. Med Phys. 2010;37(1):108-15.
10. Bedford JL, Lee YK, Wai P, South CP, Warrington AP. Evaluation of the Delta4 phantom for IMRT and VMAT verification. Phys Med Biol. 2009;54(9):N167-N176.
11. Harms Sr WB, Low DA, Wong JW, Purdy JA. A software tool for the quantitative evaluation of 3D dose calculation algorithms. Med Phys. 1998;25(10):1830-36.
12. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656-61.
13. Zhen H, Nelms BE, Tomé WA. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Med Phys. 2011;38(10):5477-89.
14. Nelms BE, Zhen H, Tomé WA. Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med Phys. 2011;38(2):1037-44.
15. Kruse JJ. On the insensitivity of single field planar dosimetry to IMRT inaccuracies. Med Phys. 2010;37(6):2516-24.
16. Yan G, Liu C, Simon TA, Peng LC, Fox C, Li JG. On the sensitivity of patient-specific IMRT QA to MLC positioning errors. J Appl Clin Med Phys. 2009;10(1):2915.
17. Olch AJ. Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA. Med Phys. 2012;39(1):81-86.
18. Nelms BE, Opp D, Robinson J, et al. VMAT QA: measurement-guided 4D dose reconstruction on a patient. Med Phys. 2012;39(7):4228-38.
19. Solberg TD, Medin PM, Mullins J, et al. Quality assurance of immobilization and target localization systems for frameless stereotactic cranial and extracranial hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S131-S135.
20. McKeever SW and Akselrod MS. Radiation dosimetry using pulsed optically stimulated luminescence of Al2O3:C. Radiat Prot Dosim. 1999;84(1-4):317-20.
21. Gaza R, McKeever SW, Akselrod MS. Near-real-time radiotherapy dosimetry using optically stimulated luminescence of Al2O3:C: mathematical models and preliminary results. Med Phys. 2005;32(4):1094-102.
22. Jursinic PA. Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements. Med Phys. 2007;34(12):4594-604.
23. Jursinic PA. Changes in optically stimulated luminescent dosimeter (OSLD) dosimetric characteristics with accumulated dose. Med Phys. 2010;37(1):132-40.
24. Kerns JR, Kry SF, Sahoo N, Followill DS, Ibbott GS. Angular dependence of the nanoDot OSL dosimeter. Med Phys. 2011;38(7):3955-62.
25. Viamonte A, da Rosa LAR, Buckley LA, Cherpak A, Cygler JE. Radiotherapy dosimetry using a commercial OSL system. Med Phys. 2008;35(4):1261-66.
26. Yukihara EG, Mardirossian G, Mirzasadeghi M Guduru S, Ahmad S. Evaluation of A2O3:C optically stimulated luminescence (OSL) dosimeters for passive dosimetry of high-energy photon and electron beams in radiotherapy. Med Phys. 2008;35(1):260-69.
27. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-73.
28. Reft CS. The energy dependence and dose response of a commercial optically stimulated luminescent detector for kilovoltage photon, megavoltage photon, and electron, proton, and carbon beams. Med Phys. 2009;36(5):1690-99.
29. Yukihara EG and McKeever SWS. Optically stimulated luminescence (OSL) dosimetry in medicine. Phys Med Biol. 2008;53(20):R351-R379.
30. Gordon JJ, Gardner JK, Wang S, Siebers JN. Reliable detection of fluence anomalies in EPID-based IMRT pretreatment quality assurance using pixel intensity deviations. Med Phys. 2012;39(8):4959-75.
31. Papanikolaou N, Battista JJ, Boyer AL, et al. Tissue inhomogeneity corrections for megavoltage photon beams: Report of Task Group No. 65 of the Radiation Therapy Committee: AAPM report No.85. Madison, WI: Medical Physics Publishing; 2004.
32. Wachowicz K, Stanescu T, Thomas SD, Fallone BG. Implications of tissue magnetic susceptibility-related distortion on the rotating magnet in an MR-linac design. Med Phys. 2010;37(4):1714-21.
33. Woo MK and J.R.Cunningham. The validity of the density scaling method in primary electron transport for photon and electron beams. Med Phys. 1990;17(2):187-94.
34. Boggula R, Lorenz F, Mueller L, et al. Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies. Phys Med Biol. 2010;55(19):5619-33.
35. Renner WD, Norton K, Holmes T. A method for deconvolution of integrated electronic portal images to obtain incident fluence for dose reconstruction. J Appl Clin Med Phys. 2005;6(4):22-39.
36. van Elmpt W, Nijsten SM, Schiffeleers RF, et al. A Monte Carlo based three-dimensional dose reconstruction method derived from portal dose images. Med Phys. 2007;33(7):2426-34.
37. van Elmpt W, Nijsten SM, Dekker AL, Mijnheer BJ, Lambin P. Treatment verification in the presence of inhomogeneities using EPID-based three-dimensional dose reconstruction. Med Phys. 2007;34(7):2816-26.
38. Wendling M, McDermott LN, Mans A, et al. In aqua vivo EPID dosimetry. Med Phys. 2012;39(1):367-77.
39. Wendling M, McDermott LN, Mans A, Sonke JJ, van Herk M, Mijnheer BJ. A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments. Med Phys. 2009;36(7):3310-21.
40. Benedict SH, Yenice KM, Followill, D et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078-101.
41. Followill DS, Evans DR, Cherry C, et al. Design, development, and implementation of the radiological physics center's pelvis and thorax anthropomorphic quality assurance phantoms. Med Phys. 2007;34(6):2070-76.